| __timestamp | Amgen Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 293000 |
| Thursday, January 1, 2015 | 4070000000 | 1002000 |
| Friday, January 1, 2016 | 3840000000 | 888000 |
| Sunday, January 1, 2017 | 3562000000 | 19623000 |
| Monday, January 1, 2018 | 3737000000 | 30421000 |
| Tuesday, January 1, 2019 | 4116000000 | 34794000 |
| Wednesday, January 1, 2020 | 4207000000 | 28304000 |
| Friday, January 1, 2021 | 4819000000 | 56886000 |
| Saturday, January 1, 2022 | 4434000000 | 100894000 |
| Sunday, January 1, 2023 | 4784000000 | 159765000 |
| Monday, January 1, 2024 | 5964000000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood that fuels innovation and growth. Amgen Inc., a stalwart in the industry, has consistently invested heavily in R&D, with expenditures peaking at nearly $4.8 billion in 2021. This represents a steady increase of approximately 35% from 2014. In contrast, Viridian Therapeutics, Inc., a rising star, has shown a remarkable growth trajectory in its R&D spending. Starting from a modest $293,000 in 2014, Viridian's investment surged to over $159 million by 2023, marking an exponential increase of over 54,000%. This stark contrast highlights the different stages and strategies of these companies, with Amgen focusing on sustaining its market leadership and Viridian aggressively expanding its research capabilities. As the biotech landscape continues to shift, these R&D investments will be crucial in determining the future leaders of the industry.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Amgen Inc. and Exelixis, Inc.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Research and Development Expenses Breakdown: Amgen Inc. vs Soleno Therapeutics, Inc.
Amgen Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioCryst Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.